Amarin Corp Plc (AMRN) ADR Each Rep 1 Ord

Sell:$0.56Buy:$0.58$0.03 (4.67%)

Prices delayed by at least 15 minutes
Sell:$0.56
Buy:$0.58
Change:$0.03 (4.67%)
Deal now
Prices delayed by at least 15 minutes
Sell:$0.56
Buy:$0.58
Change:$0.03 (4.67%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.

Key people

Aaron D. Berg
President, Chief Executive Officer, Director
Peter Fishman
Chief Financial Officer
Stephen B. Ketchum
President - Research and Development, Executive Vice President, Chief Scientific Officer
Jonathan N Provoost
Executive Vice President, Chief Legal and Compliance Officer, Secretary
Odysseas D. Kostas
Non-Executive Independent Chairman of the Board
Patrice Bonfiglio
Non-Executive Independent Director
Paul Cohen
Non-Executive Independent Director
Mark Dipaolo
Non-Executive Independent Director
Keith L. Horn
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    Ireland
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US0231112063
  • Market cap
    $243.51m
  • Employees
    275
  • Shares in issue
    422.07m
  • Exchange
    NASDAQ
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.